HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

NP 06-1

contains extracts of Phellodendron amurense bark and Citrus sinensis peel for treatment of osteoarthritis

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Plant Preparations: 622
    - Plant Extracts: 3916
      - NP 06-1: 2
Pharmaceutical Preparations
- Plant Extracts: 3916
  - NP 06-1: 2

Experts

1.	Chambliss, Walter: 2 articles (08/2009 - 05/2008)
2.	Dolnick, Deanne: 2 articles (08/2009 - 05/2008)
3.	Enonchong, Ebangha: 2 articles (08/2009 - 05/2008)
4.	Garrison, Robert: 2 articles (08/2009 - 05/2008)
5.	Kothari, Shil: 2 articles (08/2009 - 05/2008)
6.	Oben, Julius: 2 articles (08/2009 - 05/2008)

Related Diseases

1.	Overweight 08/14/2009 - "An 8-week placebo-controlled, randomized, double-blind study was conducted with four groups comparing the effects of NP 06-1 to placebo on overweight and normal weight subjects diagnosed with primary osteoarthritis of the knee. " 08/14/2009 - "The objective of this clinical study was to assess the potential benefit of a dietary supplement, NP 06-1, on joint health in overweight and normal weight adults diagnosed with osteoarthritis. " 05/20/2008 - "An 8-week, placebo-controlled, randomized, double-blind study was conducted with four groups, comparing the effects of NP 06-1 to placebo in overweight and normal weight subjects diagnosed with primary osteoarthritis of the knee. " 05/20/2008 - "The objective of this clinical study was to assess the potential benefit of a dietary supplement, NP 06-1, on cardiovascular protective properties in overweight and normal weight adults diagnosed with osteoarthritis of the knee. "
2.	Knee Osteoarthritis 08/14/2009 - "In this pilot study, NP 06-1 had beneficial effects on symptoms of osteoarthritis of the knee as measured using LAI scores and had anti-inflammatory effects as measured using CRP. " 08/14/2009 - "An 8-week placebo-controlled, randomized, double-blind study was conducted with four groups comparing the effects of NP 06-1 to placebo on overweight and normal weight subjects diagnosed with primary osteoarthritis of the knee. " 05/20/2008 - "An 8-week, placebo-controlled, randomized, double-blind study was conducted with four groups, comparing the effects of NP 06-1 to placebo in overweight and normal weight subjects diagnosed with primary osteoarthritis of the knee. " 05/20/2008 - "The objective of this clinical study was to assess the potential benefit of a dietary supplement, NP 06-1, on cardiovascular protective properties in overweight and normal weight adults diagnosed with osteoarthritis of the knee. "
3.	Weight Loss (Weight Reduction) 08/14/2009 - "Administration of NP 06-1 was also associated with weight loss, which may have been a contributing factor to the other benefits." 05/20/2008 - "Administration of NP 06-1 was also associated with weight loss."
4.	Osteoarthritis 08/14/2009 - "The objective of this clinical study was to assess the potential benefit of a dietary supplement, NP 06-1, on joint health in overweight and normal weight adults diagnosed with osteoarthritis. "